Cargando…
Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial
The purpose of this study is to evaluate the direct and indirect effects of a web-based, Protection Motivation Theory (PMT)–informed breast cancer education and decision support tool on intentions for risk-reducing medication and breast MRI among high-risk women. Women with ≥ 1.67% 5-year breast can...
Autores principales: | Conley, Claire C., Wernli, Karen J., Knerr, Sarah, Li, Tengfei, Leppig, Kathleen, Ehrlich, Kelly, Farrell, David, Gao, Hongyuan, Bowles, Erin J. A., Graham, Amanda L., Luta, George, Jayasekera, Jinani, Mandelblatt, Jeanne S., Schwartz, Marc D., O’Neill, Suzanne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124715/ https://www.ncbi.nlm.nih.gov/pubmed/34813048 http://dx.doi.org/10.1007/s13187-021-02114-y |
Ejemplares similares
-
Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial
por: Wernli, Karen J, et al.
Publicado: (2021) -
Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer
por: Jayasekera, Jinani, et al.
Publicado: (2023) -
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer
por: Jayasekera, Jinani, et al.
Publicado: (2019) -
Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions
por: Jayasekera, Jinani, et al.
Publicado: (2021) -
Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics
por: Chandler, Young, et al.
Publicado: (2021)